NCT02935595View on ClinicalTrials.gov

Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 14, 2016

Primary Completion Date

August 16, 2017

Study Completion Date

August 16, 2017

Conditions
Treatment Resistant Depression
Interventions
DRUG

Ketamine

Ketamine Hydrochloride Injection

Trial Locations (1)

77021

Harris County Psychiatric Center, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02935595 - Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients | Biotech Hunter | Biotech Hunter